Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kast

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Current Issues in Molecular Biology|March 26, 2025
Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 RegimenRichard E Kast
Springerplus|November 7, 2015
Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessR E Kast
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiationRichard E Kast
Turkish Neurosurgery|October 22, 2010
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunctRichard E Kast
Annales Pharmaceutiques Francaises|March 10, 2021
Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiationR E Kast
British Journal of Haematology|April 14, 2006
Aspirin use in myeloma: a note of caution regarding potential tumour necrosis factor-alpha elevationR E Kast
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1976
Introduction to the scrapie diseases: self-replicating agents surviving standard autoclaving for an hour and 10% formalin for a yearR E Kast
Lancet (London, England)|March 27, 2001
Dementia and statinsR E Kast
International Immunopharmacology|November 17, 2001
Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alphaR E Kast
Molecular Immunology|August 29, 2003
Tenofovir, COX inhibitors and zileuton during cancer immunotherapies: up-regulated TNF-alpha increases antigen driven lymphocyte proliferationR E Kast
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Current Issues in Molecular Biology|March 26, 2025
Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 RegimenRichard E Kast
Springerplus|November 7, 2015
Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessR E Kast
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiationRichard E Kast
Turkish Neurosurgery|October 22, 2010
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunctRichard E Kast
Annales Pharmaceutiques Francaises|March 10, 2021
Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiationR E Kast
British Journal of Haematology|April 14, 2006
Aspirin use in myeloma: a note of caution regarding potential tumour necrosis factor-alpha elevationR E Kast
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1976
Introduction to the scrapie diseases: self-replicating agents surviving standard autoclaving for an hour and 10% formalin for a yearR E Kast
Lancet (London, England)|March 27, 2001
Dementia and statinsR E Kast
International Immunopharmacology|November 17, 2001
Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alphaR E Kast
Molecular Immunology|August 29, 2003
Tenofovir, COX inhibitors and zileuton during cancer immunotherapies: up-regulated TNF-alpha increases antigen driven lymphocyte proliferationR E Kast
Pageof 18